Genus (LON:GNS) Earns Buy Rating from Shore Capital

Key Points

• Shore Capital has restated a "buy" rating on Genus (LON:GNS) with a price target of GBX 2,900, indicating a potential upside of 2.65%.
• Deutsche Bank has also raised its price objective for Genus from GBX 2,250 to GBX 2,550, further affirming a buy recommendation.
• Genus shares have increased by 13.0% recently, currently trading at GBX 2,825, with a market capitalization of £1.86 billion.

Shore Capital reiterated their buy rating on shares of Genus (LON:GNS - Free Report) in a research note published on Thursday, Marketbeat reports. They currently have a GBX 2,900 price target on the stock.

Separately, Deutsche Bank Aktiengesellschaft boosted their target price on Genus from GBX 2,250 to GBX 2,550 and gave the stock a "buy" rating in a research report on Tuesday, July 15th. Two investment analysts have rated the stock with a Buy rating, According to MarketBeat.com, the stock presently has an average rating of "Buy" and a consensus target price of GBX 2,725.

Genus Stock Performance

Shares of LON:GNS traded up GBX 25 during midday trading on Thursday, reaching GBX 2,695. 109,841 shares of the company traded hands, compared to its average volume of 259,126. The company has a quick ratio of 1.08, a current ratio of 1.80 and a debt-to-equity ratio of 53.12. Genus has a 12 month low of GBX 1,424 and a 12 month high of GBX 3,228.80. The firm has a market capitalization of £1.77 billion, a price-to-earnings ratio of -43,467.74, a price-to-earnings-growth ratio of 2.87 and a beta of 0.37. The firm's fifty day moving average price is GBX 2,464.17 and its two-hundred day moving average price is GBX 2,092.77.

Genus (LON:GNS - Get Free Report) last posted its earnings results on Thursday, September 4th. The company reported GBX 81.80 EPS for the quarter. Genus had a return on equity of 1.41% and a net margin of 1.18%. On average, equities analysts expect that Genus will post 70.9644323 earnings per share for the current year.

Genus Company Profile

Genus plc operates as an animal genetics company in North America, Latin America, the United Kingdom, rest of Europe, the Middle East, Russia, Africa, and Asia. The company operates through three segments: Genus PIC, Genus ABS, and Genus Research and Development. It sells breeding pigs and semen to breed pigs with various characteristics for pork production under the PIC brand.